Judy Wawira Gichoya

Multi-site real-world performance of commercial AI for pulmonary and incidental pulmonary embolism detection

Pulmonary embolism (PE) is a leading cause of cardiovascular mortality, yet the real-world performance of FDA-cleared AI detection models remains incompletely characterized. We retrospectively evaluated two FDA-cleared AI algorithms from a single commercial platform (Aidoc Medica...